UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): May 5, 2003
MYMETICS CORPORATION
(Exact name of Registrant as specified in its charter)
DELAWARE
(State of Incorporation)
000-25132 25-1741849
(Commission File Number) (I.R.S. Employer Identification No.)
150 CHESTNUT STREET
PROVIDENCE, RHODE ISLAND 02903
(Address of principal executive offices)
706 GIDDINGS AVENUE, SUITE 1 C
ANNAPOLIS, MARYLAND 21401-1472
(Former Address)
50-52 AVENUE DU CHANOINE CARTELLIER
69230 SAINT-GENIS LAVAL, FRANCE
(Former Address)
401-861-7604
(Registrant's telephone number, including area code)
ITEM 5. OTHER EVENTS.
On May 5, 2003, Dr. Pierre Francois Serres was terminated as our Chief
Scientific Officer. On April 22, 2003, our board of directors gave Dr. Serres
notice that he was, in various respects, in breach of his employment agreement.
Pursuant to the employment agreement, Dr. Serres was given an opportunity to
cure such breaches. The breaches were not cured and Dr. Serres' employment with
us was terminated effective May 5, 2003. Dr. Serres is still a member of our
board of directors.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Date: May 8, 2003 MYMETICS CORPORATION
By: /s/ John Musacchio
--------------------
John Musacchio,
Chief Financial Officer,
Secretary and Director